These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 30397055

  • 21. An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus.
    Cui L, Isii T, Fukuda M, Ochiai T, Neoh HM, Camargo IL, Watanabe Y, Shoji M, Hishinuma T, Hiramatsu K.
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5222-33. PubMed ID: 20837752
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of telavancin susceptibility in isolates of Staphylococcus aureus with reduced susceptibility to vancomycin.
    McMullen AR, Lainhart W, Wallace MA, Shupe A, Burnham CD.
    Eur J Clin Microbiol Infect Dis; 2019 Dec; 38(12):2323-2330. PubMed ID: 31446513
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of the ATP Synthase Eliminates the Intrinsic Resistance of Staphylococcus aureus towards Polymyxins.
    Vestergaard M, Nøhr-Meldgaard K, Bojer MS, Krogsgård Nielsen C, Meyer RL, Slavetinsky C, Peschel A, Ingmer H.
    mBio; 2017 Sep 05; 8(5):. PubMed ID: 28874470
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
    Capone A, Cafiso V, Campanile F, Parisi G, Mariani B, Petrosillo N, Stefani S.
    Eur J Clin Microbiol Infect Dis; 2016 Apr 05; 35(4):625-31. PubMed ID: 26815434
    [Abstract] [Full Text] [Related]

  • 26. A mutation in the PP2C phosphatase gene in a Staphylococcus aureus USA300 clinical isolate with reduced susceptibility to vancomycin and daptomycin.
    Passalacqua KD, Satola SW, Crispell EK, Read TD.
    Antimicrob Agents Chemother; 2012 Oct 05; 56(10):5212-23. PubMed ID: 22850507
    [Abstract] [Full Text] [Related]

  • 27. Genome sequence of Staphylococcus aureus VC40, a vancomycin- and daptomycin-resistant strain, to study the genetics of development of resistance to currently applied last-resort antibiotics.
    Sass P, Berscheid A, Jansen A, Oedenkoven M, Szekat C, Strittmatter A, Gottschalk G, Bierbaum G.
    J Bacteriol; 2012 Apr 05; 194(8):2107-8. PubMed ID: 22461548
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin.
    Sakoulas G, Alder J, Thauvin-Eliopoulos C, Moellering RC, Eliopoulos GM.
    Antimicrob Agents Chemother; 2006 Apr 05; 50(4):1581-5. PubMed ID: 16569891
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure.
    Kelley PG, Gao W, Ward PB, Howden BP.
    J Antimicrob Chemother; 2011 May 05; 66(5):1057-60. PubMed ID: 21393156
    [Abstract] [Full Text] [Related]

  • 33. Phenotypic and genotypic correlates of daptomycin-resistant methicillin-susceptible Staphylococcus aureus clinical isolates.
    Kang KM, Mishra NN, Park KT, Lee GY, Park YH, Bayer AS, Yang SJ.
    J Microbiol; 2017 Feb 05; 55(2):153-159. PubMed ID: 28120188
    [Abstract] [Full Text] [Related]

  • 34. Impact of Multiple Single-Nucleotide Polymorphisms Within mprF on Daptomycin Resistance in Staphylococcus aureus.
    Yang SJ, Mishra NN, Kang KM, Lee GY, Park JH, Bayer AS.
    Microb Drug Resist; 2018 Oct 05; 24(8):1075-1081. PubMed ID: 29381428
    [Abstract] [Full Text] [Related]

  • 35. Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.
    Bennett JW, Murray CK, Holmes RL, Patterson JE, Jorgensen JH.
    Diagn Microbiol Infect Dis; 2008 Apr 05; 60(4):437-40. PubMed ID: 18096352
    [Abstract] [Full Text] [Related]

  • 36. Stepwise decrease in daptomycin susceptibility in clinical Staphylococcus aureus isolates associated with an initial mutation in rpoB and a compensatory inactivation of the clpX gene.
    Bæk KT, Thøgersen L, Mogenssen RG, Mellergaard M, Thomsen LE, Petersen A, Skov S, Cameron DR, Peleg AY, Frees D.
    Antimicrob Agents Chemother; 2015 Nov 05; 59(11):6983-91. PubMed ID: 26324273
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Daptomycin non-susceptible Staphylococcus aureus at a US medical centre.
    Velazquez A, DeRyke CA, Goering R, Hoover V, Wallace MR.
    Clin Microbiol Infect; 2013 Dec 05; 19(12):1169-72. PubMed ID: 23480569
    [Abstract] [Full Text] [Related]

  • 39. Characterization of compensatory mutations associated with restoration of daptomycin-susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus and the role mprF mutations.
    Kanesaka I, Fujisaki S, Aiba Y, Watanabe S, Mikawa T, Katsuse AK, Takahashi H, Cui L, Kobayashi I.
    J Infect Chemother; 2019 Jan 05; 25(1):1-5. PubMed ID: 30322736
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.